Should Canopy Growth Corp. Be a Top Pick for 2018?

Canopy Growth Corp. (TSX:WEED) has enjoyed a stellar 2017. Are more gains on the way next year?

Canopy Growth Corp. (TSX: WEED) has been a profitable pick for investors this year, and those who’ve missed out on the big rally are wondering if more gains could be on the way in 2018.

Let’s take a look at the current situation to see if the stock deserves to be in your portfolio.

Medical marijuana leader

Canopy is the leader in Canada’s medical marijuana market. The company has done a good job of making strategic acquisitions at opportune times, including the purchase of Mettrum Health earlier this year.

Canopy currently provides medical marijuana to more than 50,000 registered patients through its online sales platform. The company offers several brands and has negotiated deals with smaller suppliers to give them access to the market through its CraftGrow program.

The move is a smart one, as it helps Canopy secure its dominant position. Smaller companies do not have the resources to build their own online platform, and by allowing other producers to use its system, Canopy gets a piece of the action while controlling the point of sale.

The company is also positioning itself for international growth. Canopy already owns a pharmaceutical distributor in Germany and has entered joint-venture, or partnership, agreements in several countries, including Spain, Australia, Denmark, Brazil, Jamaica, and Chile.

Recreational opportunities

Canopy’s stock has rallied on the hopes that Canada will open its recreational marijuana market next summer.

The federal government appears determined to follow through with its schedule, and the provinces are slowly revealing blueprints for how they plan to run the industry in their respective jurisdictions.

Ottawa has placed the majority of the burden on the provinces, so most of the details on pricing and distribution have to be sorted out at the provincial level.

Whether or not the provinces will be able to hit the ground running on July 1, 2018, is yet to be seen, but investors seem to think the odds are pretty good.

Canopy also received a boost after Constellation Brands, which owns Corona, announced an agreement to take a 9.9% stake in the marijuana producer.

Constellation plans to sell cannabis-infused beverages in markets that allow the recreational use of marijuana.

Should you buy for 2018?

At the time of writing, Canopy trades for $19.20 per share. That’s nearly triple the price some investors paid for the stock in early June, and translates into a market capitalization of more than $3.65 billion.

Based on the company’s most recent quarter, the stock is very expensive. Canopy reported revenue of $17.6 million and a net loss of $1.6 million.

As a result, investors who buy today have to be convinced the recreational market will open as planned, and the company will capture a significant part of that market, which pundits say is worth at least $5 billion.

Management is doing all the right things, and Canopy could very well grow into its valuation quite quickly. However, given the large rally in the past six months, I would probably wait for a pullback before adding the stock to your portfolio.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

a person watches a downward arrow crash through the floor
Dividend Stocks

A TFSA Loss Doesn’t Create New Room: Here’s the Rebuilding Plan I’d Use

A falling investment won’t create TFSA contribution room. I’d rebuild using the room I actually have and a portfolio that…

Read more »

Forklift in a warehouse
Dividend Stocks

A 7.9% Dividend Stock for Monthly Retirement Income

This Canadian REIT trades at a 38.8% discount to a key valuation measure, and offers a 7.9% yield, paid monthly,…

Read more »

hand stacks coins
Dividend Stocks

Building a $1,000-a-Month Dividend Income Stream: What It Actually Takes

Wondering what it takes to earn $1,000/month in dividends? Here's some different scenarios and stocks that can help get you…

Read more »

A series of red ladders lead to successively higher levels
Dividend Stocks

Colliers Stock: The Engineering Business Behind the Real Estate Name

Colliers still earns from real estate, but engineering now gives investors a second business to follow.

Read more »

shopper checks her receipt
Dividend Stocks

2 Safe Canadian Stocks to Buy With $7,000

Loblaw (TSX:L) and another safety play that could be a great fit for Canadian investors seeking lower betas and greater…

Read more »

dreaming of financial success
Dividend Stocks

Telus vs. Fortis: Which Stock Would I Choose for a More Dependable Payout?

Telus pays more today after its reset. I’d choose Fortis for the payout I’d rather count on over several years.

Read more »

a person looks out a window into a cityscape
Dividend Stocks

This 3% Dividend Stock Pays Cash Out Every Month

Boardwalk REIT pays $0.15 a unit every month, a yield near 3%. See Q3 results, the buyback story and the…

Read more »

shoppers in an indoor mall
Dividend Stocks

2 Top TSX Dividend Stocks With High Yields Worth Considering Now

These TSX stocks offer high yields of over 5.5%, have sustainbale payouts, and are well-positioned to keep paying their dividends.

Read more »